1.Worsening of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in patients with prostate cancer after androgen deprivation therapy.
Ryo OKA ; Takanobu UTSUMI ; Takumi ENDO ; Masashi YANO ; Shuichi KAMIJIMA ; Naoto KAMIYA ; Hiroyoshi SUZUKI
Asian Journal of Andrology 2018;20(6):634-636
Aged
;
Androgen Antagonists/adverse effects*
;
Anticholesteremic Agents/therapeutic use*
;
Cholesterol, HDL/blood*
;
Cholesterol, LDL/blood*
;
Humans
;
Hypercholesterolemia/chemically induced*
;
Lipids/blood*
;
Male
;
Middle Aged
;
Prostatic Neoplasms/therapy*
;
Retrospective Studies
;
Testosterone/blood*
Result Analysis
Print
Save
E-mail